Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
gptkb:granulocyte_colony-stimulating_factor |
| gptkbp:approvalYear |
2012
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
L03AA10
|
| gptkbp:brand |
gptkb:Granix
|
| gptkbp:CASNumber |
1211813-36-9
|
| gptkbp:chemicalClass |
gptkb:protein
|
| gptkbp:hasMolecularFormula |
C845H1343N223O243S9
|
| https://www.w3.org/2000/01/rdf-schema#label |
tbo-filgrastim
|
| gptkbp:indication |
reduce duration of neutropenia
reduce incidence of infection |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
gptkb:Teva_Pharmaceuticals
|
| gptkbp:mechanismOfAction |
stimulates production of neutrophils
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:producedBy |
recombinant DNA technology
|
| gptkbp:relatedTo |
gptkb:filgrastim
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:sideEffect |
fever
injection site reaction bone pain |
| gptkbp:UNII |
6M8Y3G0A6F
|
| gptkbp:usedFor |
neutropenia
chemotherapy-induced neutropenia |
| gptkbp:bfsParent |
gptkb:Granix
|
| gptkbp:bfsLayer |
8
|